Hemp News, Laws & Product Updates

A curated news hub focused on hemp regulation and policy changes, cannabinoids (CBD/Delta-8/Delta-9/hemp-derived THC), lab testing and COAs, product safety, brands, and industry trends.

Federal & State Hemp Laws
THC Policy
CBD / Delta-8
Compliance
Lab Testing (COA)
Product Safety
Industry & Brands

Back to Chow420

https://hightimes.com/

Gallup: 17% of American Adults Smoke Pot

Seventeen percent of Americans aged 18 and older reported smoking pot in 2023. That is largely unchanged from Gallup’s most recent findings on the matter. In 2022, 16% of American adults said they smoke marijuana. But the 17% figure represents a marked increase since 2013, when Gallup first added the question to its annual survey measuring Americans’ consumption habits. That year, a mere seven percent of American adults identified as marijuana smokers. “Age is a significant driver of the likelihood of smoking marijuana. About a quarter of young adults, those aged 18 to 34, say they smoke marijuana (26%), but reported use falls to 18% among adults aged 35 to 54 and is even lower, 11%, among adults aged 55 and older,” Gallup said in its analysis. Gallup noted other divides in the responses along gender, education level and party identification. “Men (19%) are more likely than women (14%) to use marijuana,” the pollster explained. “College graduates (9%) are about half as likely as those without a college degree (21%) to smoke marijuana. Democrats (22%) are more likely than Republicans (12%) to report smoking marijuana, with independents’ rate (17%) falling between them.” The survey also included a separate question concerning previous marijuana use. On this, half of American adults––50%––said they have tried cannabis. “Gallup’s much longer trend on ever having tried marijuana shows that experimentation increased sharply in the first decade after the initial measure. Between 1969 and 1977, it jumped 20 percentage points, from 4% to 24%. It rose another nine points by 1985, to 33%, but thereafter stalled at under 40% until 2015, when it ticked up to 44%. It remained at about that level through 2019 but then rose to 49% in 2021, roughly where it is today,” Gallup said. Gallup’s polling on Americans’ attitudes toward marijuana has captured a country undergoing a seachange when it comes to drug policy. In November, Gallup published a poll revealing that seven in 10 Americans believe marijuana use should be legal, which was “the highest level yet after holding steady at 68% for three years.” Gallup explained that only 12% of Americans supported legalization when it asked about it in 1969. But ever since states took the lead and ended pot prohibition nearly 12 years ago, public opinion has shifted dramatically. “Support cracked the 50% threshold in 2013, jumping 10 percentage points to 58% after Colorado and Washington became the first states to legalize the recreational use of marijuana,” Gallup said in its analysis. “Support has since increased by another 12 points, paralleling the rise in Americans’ self-reported use of the drug. According to Gallup’s July Consumption Habits survey, the percentage saying they personally smoke marijuana has risen 10 points to 17% since 2013, and the percentage who have ever tried it has increased 12 points to 50%.” The poll also marked the second consecutive year in which “majority support for legalization is found among all major subgroups, including by age, political party and ideology,” Gallup said. “Self-identified conservatives were the last major subgroup to express majority support, reaching 51% in 2022. Republicans first gave marijuana majority-level backing in 2017. As of today, support for legal marijuana use is highest among self-identified liberals (91%) and Democrats (87%) and lowest among conservatives (52%) and Republicans (55%). Support is inversely correlated with age, reaching 79% among 18- to 34-year-olds. However, even among the oldest age group, nearly two-thirds (64%) are in favor,” Gallup reported. “There are no significant differences in support by gender, race or education. While most of the regional differences seen this year are also not statistically significant, the lower support for legalization in the East than in the West and Midwest is consistent with the recent trend.” But another finding released by Gallup around that same time showed that, for the first time, “a majority of U.S. adults, 52%, say the U.S. has lost ground in coping with the illegal drug problem, while a record-low 24% say it has made progress.” Those findings, per Gallup, “mark a sharp reversal from the prior reading in 2019.” “At that time, more Americans were optimistic that progress was being made (41%) than believed the U.S. was losing ground (30%) in the effort. For most other recent readings, Americans were divided as to whether things were improving or getting worse,” Gallup said. “The public was most optimistic about the nation’s coping with illegal drugs in 1999 and 2000, when an average of 47% believed the U.S. was making progress on the issue.”

https://hightimes.com/

‘Old Smoker’ Star Discovered Lurking in Milky Way Galaxy

A strange new type of star referred to by scientists as an “old smoker” has been discovered after a years-long astronomical study. According to four different studies recently published in Monthly Notices of the Royal Astronomical Society, these recently discovered stellar objects are essentially really large and very old stars that emit puffs of what appears to be smoke and dust after many decades of inactivity. These stars were discovered using a powerful giant telescope located deep in the mountains of Chile. Lead author of one study and co-author of the other three, Phillip Lucas, said that thus far, scientists are not completely sure what creates this effect in the old smoker stars. “Everything we have been able to learn about them suggests that this is a case of stars throwing off puffs of smoke—for reasons that we don’t fully understand,” Lucas said. “We weren’t sure if these stars were protostars starting an eruption, or recovering from a dip in brightness caused by a disc or shell of dust in front of the star — or if they were older giant stars throwing off matter in the late stages of their life,” Lucas said Originally the studies were focused at finding newborn stars, oftentimes surrounded by dust and gasses making them hard to see. This is why the VISTA (Visible and Infrared Survey Telescope) in Chile, capable of seeing infrared light, was used to scan the skies for the stars other telescopes would not be able to see. As Dr. Zhen Guo, Fondecyt Postdoc Fellow at the University of Valparaiso in Chile and lead author of two studies explained, these newborn stars often help to form new solar systems over time. “Our main aim was to find rarely-seen newborn stars, also called protostars, while they are undergoing a great outburst that can last for months, years, or even decades,” Guo said. “These outbursts happen in the slowly spinning disc of matter that is forming a new solar system. They help the newborn star in the middle to grow, but make it harder for planets to form. We don’t yet understand why the discs become unstable like this,” Guo said. The old smoker stars are a kind of red giant. Red giants are stars which have essentially expired, that is, they’ve run out of hydrogen fuel and have “died” in a sense. This often causes violent energy outbursts from the star for a while. Our own sun will go through this one day in the far off future, swallowing several of the inner planets in the course of its death according to NASA, though the fate of the Earth remains relatively unclear when this happens. Luckily, it’ll be several billion years before this occurs so it will more than likely be somebody else’s problem by then. The team of scientists involved with these studies found several red giants, 21 to be exact, that appeared to be a bit different than those found in the past. They chose seven of these stars to focus on and noticed unusual characteristics that puzzled them, most noticeably the smoke and dust they appeared to exert which is how they received the moniker ‘old smoker.’ “These elderly stars sit quietly for years or decades and then puff out clouds of smoke in a totally unexpected way,” said Dante Minniti, a professor in the department of physics at Andrés Bello University in Chile and coauthor on three of the studies, in a press release “They look very dim and red for several years, to the point that sometimes we can’t see them at all.” Most of the stars the team studied were found near the center or the nucleus if you will of the Milky Way Galaxy, known as the innermost nuclear disc. Lucas explained that these newly discovered stars could potentially play a role in the way elements are distributed across the galaxies. “Matter ejected from old stars plays a key role in the life cycle of the elements, helping to form the next generation of stars and planets,” Lucas said. “This was thought to occur mainly in a well-studied type of star called a Mira variable. However, the discovery of a new type of star that throws off matter could have wider significance for the spread of heavy elements in the Nuclear Disc and metal-rich regions of other galaxies.”

https://hightimes.com/

Sen. Elizabeth Warren Advocates for Cannabis Descheduling on ‘The Late Show’

This year is shaping up to potentially be one of the most historic when it comes to cannabis, as U.S. advocates and consumers alike await the final decision from the Drug Enforcement Administration (DEA) on whether it will reschedule cannabis from a Schedule I to Schedule III controlled substance. After the U.S. Department of Health and Human Services (HHS) made its recommendation to the DEA in December 2023, the collective excitement for a final decision is palpable. There has even been a recent wave of rumors that the White House could make an announcement about the pending review in the coming days, though a Biden administration official denied any pending announcements for the upcoming week. As the wait continues, a number of advocates and legislators are arguing that simply moving cannabis to another category is not enough and pushing to deschedule cannabis entirely. Among those leaders is Sen. Elizabeth Warren (D-MA), who appeared on The Late Show earlier this week to discuss her stance. After a segment focusing on the economy and inflation, host Stephen Colbert pivoted to address a letter from last week led by Warren and Sen. John Fetterman (D-PA), along with nine other Democrats including U.S. Senate Majority Leader Chuck Schumer, Sen. Cory Booker (D-NJ) and Sen. Bernie Sanders (I-VT) among others. The letter urges the DEA and Biden administration to deschedule cannabis altogether, recognizing that rescheduling to Schedule III would be a “significant step forward” but would not resolve the “worst harms of the current system.” “Thus, the DEA should deschedule marijuana altogether. Marijuana’s placement in the CSA has had a devastating impact on our communities and is increasingly out of step with state law and public opinion,” the legislators said in the letter dated Jan. 30. “Last week you, Sen. Fetterman, Sen. Schumer and Sen. Sanders sent a letter to the DEA asking for marijuana to be descheduled. How is that different?” Colbert posed. “Two part question — How is that different from legalization, and are you high right now?” After laughs from the audience, Warren said that cannabis legalization would be possible with a “functional Congress,” adding that this is “not the world we live in.” Descheduling, she argued, is an alternative that doesn’t require Congressional approval. “Right now marijuana is scheduled, it’s called, as a drug by the DEA at the same risk as heroin,” Warren said. “And that means not only is it illegal, you can’t even do research on it. It’s, so no — and what we’re saying in this letter is, ‘Guys get with it,’ at the DEA. It’s not 1954. More than half of all states have legalized marijuana.” Research on cannabis is still possible with its current scheduling, though it has historically come with a number of obstacles that have been long criticized as barriers to opening up more cannabis-related studies. Descheduling cannabis would effectively remove its status as a controlled substance, thereby removing criminal penalties and essentially legalizing it. Congress would still be needed to establish a regulatory framework, and it would likely be treated similar to alcohol, with states allowed to form their own cannabis laws. Federal law and regulation could also play a part to some degree. Rescheduling cannabis from Schedule I to Schedule III would keep it as a controlled substance, and it would not federally legalize cannabis or allow states to facilitate their own markets. It would, however, remove research barriers and allow cannabis businesses licensed by the state to take federal tax deductions, which is currently not allowed. While rescheduling alone would not enable the shift, many have also expressed concern that moving cannabis from Schedule I to Schedule III would open the door for Big Pharma to seize the market. “The idea is to say, at the federal level, instead of creating this conflict, which is causing all kinds of problems—we’ve got problems with banking laws and problems in tax laws—you just say deschedule,” Warren said. “And look, we need some restrictions. Of course, let’s treat it like alcohol. We need to deschedule it, join the 21st century and let’s make marijuana legal. It shouldn’t be that hard.” The declaration was met with applause, followed by Colbert’s jest, “I want to point out you didn’t answer my second question.” Warren exchanged a grin back to the host as Colbert ended the segment. The full clip can be viewed here.

https://hightimes.com/

Binoid’s Best THC Vapes of 2024

It’s safe to say that 2023 was the year of THC disposables, with top-selling brands being more creative than ever before, with a wide array of cannabinoid blends, technological features, supersized cartridges, and more. Now that we’ve entered a new year, we’re going to break down the 15 most exceptional THC disposable/rechargeable vapes you can get for your 2024 cannabinoid-related needs. The best part, you can try the best THC disposables of 2024 with code HIGHTIMES25 for 25% off with fast and free shipping here. These 15 THC vapes all offer reliable hardware, pure, additive-free hemp extracts, and strain selections that go above and beyond to keep every enthusiast out there totally satisfied. Let’s get to it, with our selection of the best THC disposable vapes for 2024. Binoid’s Delta 8 THC Rechargeable Disposable Vape has been a staple of their catalog since before 2023, but what’s impressive is how it remains a top seller throughout the industry to this day. Offering a gram of vape oil, this rechargeable all-in-one device offers delta 8 THC distillate combined with the terpene profiles of dreamy strains like Gelato, Lemon Haze, Blue Dream, and others, all of which are incredibly in demand. Offering a balanced blend of delta 11 THC and 11 HXY THC, this 2-gram vape can deliver particularly long-lasting psychoactive effects thanks to the use of 11 HXY THC, a metabolite that is produced when we eat edibles. It doesn’t hurt that it comes in two ultra-rare, sought-after strains: This Slapz and Cherry Bonkerz, both renowned for their delicious flavors. Delta 9P is the stronger and more potent version of THC-P, which is 33x stronger than Delta 9 THC already. Blazed Delta 9P vapes are 3 grams blended with THC-JD plus THCA liquid diamonds, acting as one of the strongest vapes on the market, period. The strain selection is surprisingly large, with enticing choices like Maui Mist, Unicorn Haze, Bully Kush, and more. The THC-P vape from Binoid contains 2 grams of vape oil, and actually contains a decent amount of delta 8 THC too, for good measure. It’s definitely on the more potent end of the spectrum, given the amount of THC-P that’s in there, and it comes in strains connoisseurs will love, like God’s Gift, Thai Chi, Aurora Indica, and many other prestigious cultivars. THCA was all the rage and the main attraction of the hemp market in 2023, and it’s not going anywhere as demand keeps on growing. This 1-gram THCA vape is the only pure 1 gram THCA vape on the market, and contains live rosin, a concentrated and deeply flavorful terpene extract with Space Cake, Strawberry Milk, Unicorn Berry, and other mouthwatering strains available. This awesome THCV Disposable comes in an Uplift and Unwind formula. With a unique blend of THCA, THCV, and CBG (Uplift) or THCA, THCV, and CBN (Unwind), this disposable is not one of the most potent on the market, and is more akin to a delta 9 high in terms of its strength, but slightly milder. And, it happens to contain a whopping 5 grams of vape oil, to boost its value. We love that it offers a unique twist on strains, coming in two options: Uplift (a sativa blend) and Unwind (an indica blend). A more innovative option in Binoid’s inventory, this vape combines THCA with THCM – a potentiator cannabinoid that can boost the effects of THCA for even more delta 9 satisfaction. It contains, again, a staggering 5 grams per disposable, and the 3 strains it comes in are virtually holy grail in their status: Vice City, Hot Lava, and Space Mountains. We’re simply obsessed with the new Active Flowers vapes from Binoid, which contain a duo of THCA and delta 9P distillates, paired with extracts of “active flowers,” which are botanicals (and mushrooms) that are known for their powerful positive effects. Explore the rare opportunity to vape blue lotus flower, passion flower, lavender, chamomile, and more to experience effects like euphoria, calm, and enhanced creativity. Binoid’s Epic Clouds vape is another totally unique option on the market, bringing together THCA, CBC, and HHC-B, again with CBC acting as a potentiator to boost the high of the other two cannabinoids. This 5-gram disposable is aesthetically on point, and offers delicious strains like Code Red, Cosmic Berry, and Sour Tropicana. Another 5-gram THCA disposable comes from the Exclusive Series, with a gorgeous combo of THCA, delta 9P, and HHC-P, acting as one of the most powerfully intoxicating vapes on the market. Its strain selection is also out of this world, with Hot Lava, Space Mountains, Alaskan Lights, and Tropical Zkittlez being fan favorites, all of which come in tasty live resin form. The Beast Mode vape really lives up to its name, with a blend of THC-B, HHC-P, and THC-H, to get you high beyond your wildest dreams. This duo is combined with powerful live resin for the ultimate vaping experience, and comes in some fascinating strains like Red and Blue Dragon, Green and Purple Dragon and more. The Knockout Blend Vape offers up 2 grams of THC-P, THC-H, and HHC-P, 3 outrageously powerful psychoactives, plus live resin. This is a cannabinoid blend that can, as the name implies, knock you out, so it’s best reserved for night time when you don’t have anything to do. It comes in two strains: Fire OG and Ice Breaker. The Power 9 Blend from Binoid delivers a trio of delta 9 THC, THC-JD, and THC-B, and it’s not as intoxicating as the other blends we’ve covered, but is, still, very potent, so be aware. The live resin amplifies the flavor, as well as the effects of strains like Kush Mints, Candy Apple, and Gas Berry. THCA, THC-P, and PHC are the superstars of the Master Blend 3 Gram THCA Vape, which consists of a generous 3 grams of vape oil, and combines these intoxicating cannabinoids with, again, live resin. King Kong and Godzilla are the strains you can choose from, and both are forces to be reckoned with in their own ways. Lastly, we’ve got the 7 Gram Blend Vape, which is a crowning achievement of Binoid’s catalog, with an unheard-of 7 grams of vape oil. With THCA, delta 9P, and delta 9H, it’s pretty much as powerful as they come in terms of its psychoactive strength, and the live resin is just the icing on the cake. Leakproof and clog-proof, it comes in absolutely astounding slushie-inspired strains that taste as good as they feel. The first 7 gram THCA vape from Binoid is next level for value and strength, and is a must try for those who use THC disposables in 2024. This was the best THC vapes of 2024. There’s nothing like vaping some delightful THC cannabinoids to enjoy a high in an effortless way – especially when they come in glorious strain options like the ones we’ve mentioned above. These 15 vapes are diverse, but what they all share in common is that they’re effective, clean, and ready to give you a psychoactive experience that’s nothing short of enchanting. If you’re ready to get your vape on, go through the selection of strains and get your hands on this exciting new development in the hemp industry today! The best part, you can try the best THC disposables of 2024 with code HIGHTIMES25 for 25% off with fast and free shipping here.

https://hightimes.com/

Pennsylvania Governor Calls On State Lawmakers To Legalize Weed

Pennsylvania Governor Josh Shapiro this week called on state lawmakers to legalize and regulate recreational marijuana, saying “It’s time to catch up” with neighboring states that have already taken the step. The governor made his plea on Tuesday during an annual budget address to unveil a $48.3 billion spending plan for the state. “I ask you to come together and send to my desk a bill that legalizes marijuana,” Shapiro told state lawmakers in his address. “But that bill should ensure the industry is regulated and taxed responsibly.” Although the Democratic governor’s budget proposal does not include a specific cannabis legalization plan, it does call on lawmakers to pass a 20% tax on recreational marijuana. The proposal assumes a January 2025 start date for adult-use cannabis sales and estimates that the state would bring in $14.8 million in tax revenue during the first year. Shapiro added that he expects Pennsylvania’s taxes on recreational marijuana to increase to approximately $250 million per year once the regulated industry is firmly established. “We’re losing out on an industry that, once fully implemented, would bring in more than $250 million in annual revenue,” Shapiro said. “And our failure to legalize and regulate this only fuels the black market and drains much-needed resources for law enforcement. It’s time to catch up.” In a written explanation of the $48.3 billion state budget, Shapiro administration officials wrote that some tax revenue from the regulated adult-use cannabis industry should be used for “restorative justice initiatives” to address decades of inequities in the enforcement of marijuana prohibition laws. Among the initiatives, the governor specifically called on lawmakers to pass legislation to expunge the records of those convicted of possession of small amounts of marijuana. Additional funds from the state’s adult-use cannabis program would go to the Department of Agriculture and the Pennsylvania State Police. The remaining revenue would be directed to the state’s general fund. In his address, the governor noted that legalizing adult-use cannabis is supported by a majority of Pennsylvania voters and that five out of six of the Keystone State’s neighbors have already ended the prohibition of marijuana for adults. “Last year, 57 percent of voters in Ohio supported an initiative to legalize recreational marijuana,” Shapiro said. “And now, Ohio, New York, New Jersey, Delaware, and Maryland – practically all of our neighbors – have legalized marijuana.” Ben Kovler, Founder, CEO and chairman at Green Thumb Industries, a multistate cannabis company that operates 18 RISE medical marijuana dispensaries in Pennsylvania, praised Shapiro’s plan to legalize adult-use cannabis. “We applaud Pennsylvania Governor Josh Shapiro for prioritizing adult-use cannabis legalization this year, including a clear, definitive launch date for sales. This call for change signals continued progress in the Northeast toward ending Prohibition 2.0 and the devastating impact it has inflicted on communities,” Kovler said in a statement to High Times. “The team at Green Thumb is ready to support the people of Pennsylvania on their journey to well-being by providing access to safe, high-quality cannabis.” Pennsylvania legalized the medicinal use of cannabis in 2016 with the passage of the Medical Marijuana Act. Under the state program, patients with one or more specified serious medical conditions are allowed to purchase and use medical marijuana. Qualifying conditions for the use of medical marijuana in Pennsylvania include cancer, epilepsy, inflammatory bowel disease, multiple sclerosis, post-traumatic stress disorder, terminal illness and others. A total of 134 licensed medical marijuana dispensaries were in operation as of last year, according to state data. Since the program’s inception, more than 1.3 million patients have been certified as medical marijuana patients in Pennsylvania, Spotlight PA reported in December. Legalizing recreational marijuana is popular with some lawmakers in Pennsylvania, especially among Democrats. In December, Democratic Senator Sharif Street and Senator Camera Bartolotta, a Republican, introduced bipartisan legislation to legalize adult-use cannabis. Getting the bill through the Pennsylvania Senate, however, may prove difficult. Senator Kim Ward, the Senate majority leader, has said she will not support the legalization of recreational marijuana until the federal government ends cannabis prohibition, according to a report from PA Spotlight.

https://hightimes.com/

Mary Jones Cannabis Bringing Its Soda, Edibles to Canada

Canada’s THC-infused beverage market is about to get more crowded. Jones Soda, the beloved soft drink company known for its quirky flavors, said on Tuesday that the arm of its cannabis business, Mary Jones, “has been approved to operate in Ontario, Canada, with additional provinces to follow.” “Starting with their THC-infused beverages, the products are currently slated for Ontario availability in Q1 24,” the company said in a press release. Jones is eyeing an additional expansion into other cannabis categories within the Canadian market in collaboration with Tilray Brands, the Canadian cannabis company. The company said in the press release that Tilray handles its manufacturing and distribution in Canada. “Jones was originally founded in Vancouver, BC. Canada and Tilray are a natural fit for our first international expansion for Mary Jones following the incredible success we’ve had in our U.S. markets,” David Knight, CEO of Jones Soda, said in a statement on Tuesday. “Canada’s recreational cannabis sales increased $466.1M CAD in July, up 1.9 % from June this year. We’re looking forward to bringing Mary Jones to Canada’s THC retailers and consumers.” Blair MacNeil, President of Tilray Canada, said that the company is “excited to partner with Mary Jones and to produce their one of a kind beverages at our state-of-the-art London, Ontario facility.” “The Mary Jones brand has seen enormous success in the United States and we look forward to being a part of their rapid growth in Canada,” MacNeil said. Jones will “launch in Ontario with its 10MG THC-sodas in a variety of Famous Jones flavors, including Berry Lemonade, Boot Rear (Root Beer) And Col.Ahhhhh (Cola), uniquely labeled for Canadian cannabis packaging and naming requirements,” the press release said. “The sodas use the same pure cane sugar recipe as mainline Jones, adapted for cannabis. Cannabis consumers in Canada can enjoy Mary Jones THC-infused sodas alone, mixed in craft cocktails, floats and much more,” the press release continued. “Mary Jones is also exploring future expansion into other cannabis categories in the Canadian market, bringing the beverage flavors into other product formats.” The cannabis firm Green Hedge “will support sales and field marketing in Canada for Mary Jones,” according to the press release. “Infused Beverages are growing at a rapid pace in Canada and around the world, including an increasing number of consumers who are shifting to it over alcohol,” said Andrew von Teichman, CEO of Green Hedge. “It creates a highly lucrative opportunity specifically for Mary Jones craft sodas and syrups. Cannabis consumers in Canada are going to love Mary Jones!” For Tilray, Tuesday’s announcement marks another significant development within its beverage portfolio. Last year, Tilray acquired eight beer and beverage brands in a deal with Anheuser-Busch. Tilray CEO and chairman Irwin D. Simon said at the time that the deal with Anheuser-Busch “both solidifies our national leadership position and share in the U.S. craft brewing market and marks a major step forward in our diversification strategy.” “We are excited to work with the teams behind these iconic brands that command great consumer loyalty and have a history of delivering strong award-winning products with tremendous growth opportunities. Tilray is fully committed to invest in and champion the future of the U.S. craft beer industry by fueling new innovation that excites and further accelerates the growth of its consumer base,” Simon said in a statement. The deal gave Tilray a number of notable brands, including Shock Top, Breckenridge Brewery and Blue Point Brewing Company. It also included 10 Barrel Brewing Company, Redhook Brewery, Widmer Brothers Brewing, Square Mile Cider Company, and HiBall Energy. In his statement at the time, Simon said the move gave Tilray “national distribution to coveted markets across the U.S. and internationally.” “In a matter of three years, Tilray has solidified its leadership position in the craft beer industry, and we fully intend to be that change agent that reinvigorates the sector. Upon federal cannabis legalization, we expect to leverage our leadership position, wide distribution network and portfolio of beloved beverage and wellness brands to include THC-based products and maximize all commercial opportunities,” Simon said. In 2020, Tilray engineered a similar deal, acquiring craft beer company Montauk Brewing. “Tilray Brands continues to strengthen our U.S. footprint and operations through investments in and growing our portfolio of leading lifestyle CPG brands that resonate powerfully with consumers,” Simon said at the time. “Montauk Brewing is an iconic brand with leading market share and distribution in the northeast. Tilray Brands intends to leverage SweetWater’s existing nationwide infrastructure and Montauk Brewing’s northeast influence to significantly expand our distribution network and drive profitable growth in our beverage-alcohol segment. This distribution network is part of Tilray’s strategy to leverage our growing portfolio of U.S. CPG brands and ultimately to launch THC-based product adjacencies upon federal legalization in the U.S.”

https://hightimes.com/

Magic Mushrooms Busts Up Amid Renewed Interest in Psychedelics

Seizures of magic mushrooms have spiked over recent years as interest in the potential benefits of psychedelics including psilocybin rose, according to the results of a new study. The study, which was conducted by researchers at NYU Langone Health, New York City, and the University of Florida, Gainesville, was published this week by the journal Drug and Alcohol Dependence. The study found that more than 1,800 pounds of psilocybin mushrooms were seized by law enforcement agencies across the nation in 2022, up from the nearly 500 pounds confiscated in 2017. The researchers found that the greatest number of seizures occurred in the Midwest (36.0%), followed by the West (33.5%). The West led with the most mushrooms seized by weight over the six years covered by the study, with 4,109 pounds or 42.6% of the total, followed closely by the South with 4,039 pounds or 41.8% of the shrooms confiscated. Seizures by weight peaked in 2021 when law enforcement agencies seized about 3,400 pounds of psilocybin mushrooms. The authors of the study, which was funded by the National Institute on Drug Abuse (NIDA), believe the increase in seizures suggests that there has been a boost in the supply of psilocybin mushrooms nationwide. “What I think the results indicate is that shroom availability has likely been increasing,” Joseph Palamar, an epidemiologist at NYU Langone Health and the main author of the new study, told NPR. Nora D. Volkow, M.D., the director of NIDA, noted that the research was conducted at a time when the potential mental health benefits of psilocybin mushrooms had received significant attention. Numerous studies have shown that psilocybin may be an effective treatment for mental health conditions including anxiety, depression, substance use disorders and post-traumatic stress disorder (PTSD). “We are in the middle of a rapidly evolving cultural, media, and legal landscape when it comes to psychedelics, and we need data to help shape informed and appropriate public health strategies,” Volkow, who was not involved in the study, said in a statement from NIDA. “Moving forward, we must continue to track data on the availability of psychedelics, patterns in use, and associated health effects to guide efforts in promoting accurate education and reducing potential harms among people who do plan to use psychedelic drugs.” Although the research into the benefits of psilocybin is promising, the psychedelic drug has not been approved by the U.S. Food and Drug Administration. Volkow is concerned that the progress in studying the drug will lead people to self-medicate with psilocybin. “Psychedelic drugs have been promoted as a potential cure for many health conditions without adequate research to support these claims,” Volkow said. “There are people who are very desperate for mental health care, and there are businesses that are very eager to make money by marketing substances as treatments or cures.” The authors of the new study believe that all the buzz about the research into psychedelics has resulted in changing attitudes surrounding psilocybin. “All of the positive coverage of psychedelics might be introducing the idea of using them to a new population that never really considered using them before,” Palamar told The New York Times. Dr. Joshua S. Siegel, a psychiatrist at Washington University in St. Louis who was not involved in the study, said that the new research is “an important part of the bigger picture of where we are headed as a nation” with psychedelics. “It’s important to understand what’s happening in terms of the health care side of things,” Siegel added. “It’s important to understand what’s happening recreationally and legally.” Although psilocybin mushrooms are still illegal at the federal level except for authorized research, the legal status of shrooms is changing at the state and local levels. Many municipalities across the country have adopted policies to effectively decriminalize magic mushrooms, and both Oregon and Colorado have passed legislation to decriminalize psilocybin and legalize supervised therapeutic use of the drug. “The greatest overall weight in seizures was out west,” Palamar said. “And I don’t think it’s coincidental that that’s where a lot of the more liberal policies are starting to take effect.” Although psilocybin therapy can have dramatic and long-lasting mental health benefits, there are risks associated with using the drug that should be considered. Siegel explained that while psychedelics are less deadly and have a lower risk of addiction than many other drugs, psilocybin can be destabilizing, particularly for people with serious mental health conditions. “People can partly or completely lose touch with reality and behave in irrational and potentially dangerous ways,” said Siegel. Officials note that the risk can be great, with the most dangerous cases potentially resulting in psychosis that can lead to impulsive behavior including suicide. “We need to be aware that the use of these drugs comes at a certain cost,” said Volkow.

https://hightimes.com/

Grateful Dead Break Billboard Record Almost 30 Years After Disbanding

The Grateful Dead have made Billboard chart history despite not being a band for nearly 30 years, with the greatest number of top 40 albums to ever make the Billboard 200. According to Billboard, the release of Dave’s Picks, Volume 49: Frost Amphitheatre, Stanford U., Palo Alto, CA (4/27/85 & 4/28/85) debuted at number 25 on the charts making the total number of top 40 releases in the Dead’s repertoire at 59, surpassing both Frank Sinatra and Elvis Presley who were previously tied for the record at 58. “Dave’s Picks” is a series of live recordings of old Grateful Dead shows put together by archivist David Lemiex, who will celebrate his 25’th year of working with the band this year. These albums are responsible for 41 of the 59 top 40 debuts and have all been released well after the 1995 death of Grateful Dead frontman Jerry Garcia in 1995. The latest release in this series sold 21,000 of the 25,000 printed album units which were all exclusively sold through Official Grateful Dead channels. “This could be the most unlikely and unexpected record in music history, and is a testament to a few things,” Lemieux said in a press release. “First and foremost is the exceptional and consistent quality of the Grateful Dead’s more than 2,000 live shows. On the heels of this is the loyalty and passion of the many Dead Heads who have made this record possible. And to top it off, the Grateful Dead have a partnership with Rhino that ensures these many album releases are produced with care, love, and respect for both the band’s music and legacy, and the Dead Heads themselves.” Even decades after disbanding the Grateful Dead has maintained a powerful presence among their fan base which seems to grow larger every day. Dead-themed merchandise and products stretch into every sector of the economy, especially among the emerging legal cannabis community. “Dead and Company,” a Grateful Dead cover/spin-off band formed by three former Dead members and others including John Mayer have been credited with spreading Grateful Dead music to a younger audience. Their tour last year saw over 840,000 attendees with over 120,000 at the final San Francisco show alone. “It’s an honor and privilege to work for this community, and our aim is to keep building on this record by delivering the quality of recordings Dead Heads have come to expect for many years ahead,” Lemieux said. “It is truly remarkable to witness the Grateful Dead’s enduring legacy and profound impact.” Mark Pinkus, President of Rhino, reinforced Lemieux’s sentiments in a statement, intimating that the success of these album releases is proof of the real, tangible influence the Dead perpetuated with their music. “Their music and culture transcend time, and this groundbreaking achievement is a testament to their ongoing influence. Rhino is honored to continue to share their meaningful and magical music with Dead Heads, both old and new,” Pinkus said. Bernie Cahill, Founding Partner of Activist Artists Management and manager of the Grateful Dead said in a statement that the release of Dave’s Picks Volume 49 was a reminder that the Grateful Dead reinvented the way live shows were performed and remembered, as is evidenced by the immense popularity of the live recordings among their fanbase. “This remarkable achievement speaks not only to the genius and vision of the Grateful Dead, it is also a reminder of their truly epic live shows that reinterpreted their great American songbook every single time they took the stage! Simply put, this is another incredible milestone for a band who has never compromised, and has always done everything on their own terms,” Cahill said. Dead and Company’s final tour was supposed to be in 2023 but they announced at the end of the tour they likely were not done, shortly thereafter announcing a string of 24 shows at the Las Vegas sphere (which currently boasts a giant deadhead image on its outer shell) from May 16 to July 16 of 2024. Dave’s Picks Vol. 50 (Palladium, New York City – 5/3/77) is slated for release in April.

https://hightimes.com/

New Jersey Introduces Digital MMJ Cards With No Registration, Renewal Fees

As New Jersey approaches the two-year anniversary of its recreational cannabis market launch this April and adult-use revenue continues to rise, regulators recently announced a new incentive for residents to secure their medical cards. The New Jersey Cannabis Regulatory Commission (NJ-CRC) announced last week that signup and renewal for its new digital medical cards will be free. According to the commission, the new digital cards will begin rolling out in a few weeks and were introduced to prioritize patient accessibility and convenience. The digital cards can be presented on a mobile device, eliminating the risk of losing or damaging a physical card while also enhancing accessibility, the commission says. Those who would still like a physical medical card are still in for a bargain, as the NJ-CRC also recently reduced its physical registration fees to $10 — they will not be required to pay again until renewal two years later, which is also a $10 fee. The entire announcement touches on a number of other topics related to New Jersey medical cannabis, with the last header hitting on “Satisfaction Among Program Participants.” It notes a recent survey, conducted by the commission, that found less than 9% of 1,000 surveyed patients said they were unsatisfied with the service they received after contacting Patient Services at the NJ-CRC. “While many respondents shared concerns about the health care provider fees, product prices, and product availability, more than half said they participate in the program to enjoy the lower price they get from regular patient discounts and not having to pay state taxes, and to have access to the strains and products available only to patients,” the commission states in the announcement. It also encourages readers to look out for dates for medical cannabis program registration clinics, which are set to be held across New Jersey in the coming months. Looking at New Jersey cannabis sales trends, the reduction in registration and renewal fees may not come as a shock. New York similarly waived its $50 medical cannabis fee in 2022, the year after it legalized recreational cannabis. And as New Jersey’s recreational cannabis market has continued to blossom, boosting overall sales numbers, its medical sales are gradually declining. In April 2022, when recreational sales launched in New Jersey, there were 128,548 total patients in the state. That number in January 2024 was only 88,670, approximately a 31% decrease in less than two years. While medical sales numbers for 2023 Q4 are not yet available, looking at year-over-year comparisons of Q3 also provides some context for just how stark this change is. Medical sales for 2022 Q3 came to about $61.1 million, while 2023 Q3 was less than half that amount at approximately $29.2 million. Conversely, recreational sales year-over-year for the same periods increased from approximately $177.7 million to $206.1 million, for 2022 and 2023’s third quarters respectively. While the NJ-CRC did not make any explicit mentions of sales trends and the decline of medical cannabis sales numbers, it’s likely that these moves were made in part to encourage more residents to take advantage of the state’s medical cannabis program. As regions introduce their own legal recreational cannabis markets, allowing access for anyone over 21 years old with a valid ID, consumers in legal cannabis states often wonder about the need for a medical card. One of the main perks for many is avoiding the taxes levied on recreational products, as mentioned by the commission in their announcement. In New Jersey, recreational cannabis products are subject to the standard 6.625% sales tax, along with the Social Equity Excise Fee which changes based on the average price of cannabis — as of Jan. 1, 2024, the fee was updated to $1.24 per ounce. Municipalities can also charge a 2% transfer fee on cannabis sales that occur within their borders. These taxes may not seem extreme given the additional taxes in some other states — Washington State has the highest cannabis taxes in the continental U.S. with its 37% excise tax, for example. While the tax rates may not be the highest, New Jersey infamously has some of the most expensive recreational cannabis in the country. Aside from the tax relief, medical programs tend to have cheaper pricing along with specialized products, higher dosage options and more. Whether these efforts will actually reverse New Jersey’s medical cannabis market trends remains to be seen; the decline in medical sales and program enrollment numbers tends to be a recurring theme in medical-only states that legalize recreational cannabis.

https://hightimes.com/

Cannabis Business Presence Increasing on the Colorado Tourism Office Website

A report from Westword pointed out that the Colorado Tourism Office (CTO) has recently begun to feature information regarding a few cannabis businesses on its website. Westword spoke with licensed cannabis party bus business owner, Sarah Woodson, confirming that the CTO contacted her last year about her The Cannabis Experience. According to CBS News, her business was the nation’s first licensed cannabis consumption bus as of February 2023. The CTO website features some of Colorado’s best places to visit and check out, from snow-related activities, white water rafting, hot springs, dining recommendations, and an updated calendar of events on the front page. As of Feb. 5, the front page doesn’t showcase any cannabis-related businesses or activities. A quick search yields just a few cannabis-related business profiles, which includes both The Cannabis Experience, Colorado Cannabis Tours, Speak Easy Vape Lounge & Cannabis Club, Ambers Alchemy, and a 420 friendly Bed and Breakfast called Arrowhead Manor. It also includes various advice articles about disposing of cannabis when leaving the state, tips for safe consumption, and more, in addition to a few older search results where the landing pages do not work or have been removed. The profiles don’t feature a date of publishing, so it’s unclear how long they’ve been up on the website. Westword points out that Speak Easy Vape Lounge & Cannabis Club opened with a temporary local permit that expired this year and is now closed. Arrowhead Manor does not hold a hospitality license, so it must conduct business as a private venue. As of July 2023, the CTO announced that in 2022, the state collected $27.7 billion in travel spending within the state from approximately 90 million tourists. This annual spending was a $5.6 billion increase, or 25% increase from revenue generated in 2021 ($22.1 billion), with an additional 5.8 million visitors more than those who visited in 2021. The press release included a variety of other facts and data regarding its growing tourism industry, which was shared from the Colorado Travel Impacts 2022 (Dean Runyan Associates) and Colorado Travel Year Report 2022 (Longwoods International). Neither of these reports mentioned cannabis. The CTO is a division under the Governor’s Office of Economic Development and International Trade (OEDIT), that is managed by the Colorado Tourism Board, which includes 11 people appointed by both the governor and four Colorado legislators. As a government-run agency, cannabis-related hospitality opportunities and events might be tricky to advertise. Currently, public cannabis consumption is illegal, so tourists seeking legal cannabis-friendly tourism must do their own research to find private businesses that cater to that interest. One of the people who was formerly on the CTO board of directors, cannabis dispensary owner Wanda James, stated that the CTO began allowing certain cannabis businesses to advertise on the Colorado tourism website after a state hospitality law (which was passed in 2019) took effect on Jan. 1, 2020. James added that progress on including cannabis on the website decreased after former director Cathy Ritter was let go by OEDIT. Advertising a business on the Colorado tourism website is free, but interested business owners must apply on the website. “To get a free listing on Colorado.com, start by filling out the form below. Note: To appear on Colorado.com, listings must be tourism related and have a physical address in Colorado,” the application form states. Toward the bottom, it requires a short description of the business, “so that we can verify you are part of the tourism industry.” Westword obtained a statement from CTO spokesperson Hayes Norris, who explained that The Cannabis Experience is very much a welcome part of the industry worth advertising. “The Cannabis Experience is a great example of that, as they offer a range of immersive cannabis tours and experiences,” said Norris.”…there have not been any formal changes to colorado.com business rules regarding licensed hospitality businesses and cannabis.” While the CTO is not yet ready to begin the task of featuring more cannabis-themed venues and activities, organizations such as the Cannabis Travel Association International are more focused on putting the spotlight on cannabis-friendly destinations both in the U.S. and other international locations as well. While Colorado was the first to implement recreational cannabis legalization back in 2014, many other states are building up their cannabis consumption laws and business as well. In New Jersey, cannabis consumption lounges were only recently approved by the New Jersey Cannabis Regulatory Commission (CRC) last month. “New Jersey’s cannabis industry is well on its way to being a billion-dollar industry, and consumption areas will likely bolster that—fostering a communal experience for those 21 and older around cannabis in a regulated and secure space,” said CRC executive director Jeff Brown. In Nevada, the most batch of consumption lounge licenses was issued in November 2023, while a number of other license holders are eyeing 2024 for the year they hope they’ll satisfy all of the requirements to open. The Las Vegas, Nevada-based Planet 13 announced in November last year that it was eyeing an April 2024 opening, and in December 2023 it confirmed that the consumption lounge would also share a space with the Las Vegas SuperStore to Koolsville Tattoo Shop.

https://hightimes.com/

Announcing the High Times Cannabis Cup SoCal: People’s Choice Edition 2024

Are you ready for the heat that will define Southern California in 2024? The High Times Cannabis Cup SoCal: People’s Choice Edition is back in town, and the offerings of cannabis flower and products are set to redefine the selection. It’s an adult-use competition celebrating some of the best cannabis products in the region—one of the largest cannabis markets of its kind on the planet. Product submissions will be accepted from cannabis retailers and businesses beginning April 1-3. Judge Kits go on-sale beginning on April 8. Judges will have nearly two months to let the Once that takes place, Judges will be expected to narrow down the winners by June 2. Judges fill out scorecards, indicating how each submission measured up. Judges assess how each strain looks, tastes, smells, effects, and burnability on a scale of one to 10. An email is automatically sent to confirm each time a strain or product review is submitted. The emails also serve as a placement point to know which strains have already been completed. These scorecards ultimately determine who wins. Finally, the winners of this highly-anticipated event will be announced via a livestream on June 16. The original High Times Cannabis Cup SoCal was first introduced as an in-person event that was held between 2015-2019. The pandemic changed things up, shifting a move into People’s Choice events which put the power in the hands of the people, in this case, the fine people of Southern California. This High Times Cannabis Cup event offers consumers the unique opportunity to experience the finest cannabis available to consumers—relative to the specific market of Southern California. For retailers, this is more than just a competition—it’s a chance to elevate products on a For cannabis brands that wish to submit products for this year’s competition, please refer to the following rules to bring your product to a global stage and compete for the esteemed High Times Cannabis Cup. Please also adhere to the following entry requirements. Flower submissions will be 1-gram samples. We will not accept any 3.5-gram entries. Pre-Rolls and infused pre-roll samples will also have the following requirements. Pre-Rolls will be capped at 2 grams of flower-only each; Infused pre-rolls will be capped at 3-gram flower equivalency or 1 gram concentrate equivalency each. For concentrates and vape pens, we will accept 5-gram samples. We will not accept any 1-gram entries—and keep in mind that batteries are required for carts. Edibles) samples will have a 100 mg THC maximum amount. Sublinguals, capsules, tinctures and topical samples will be capped with a 500mg THC max. Competitors should note the entry fees are dependent upon how many products they submit. While one entry is $250, and two entries will be priced at $100 per entry, both non-refundable, and submissions of three or more entries is a $100 refundable deposit per entry held, which is refunded when all entries are successfully submitted. Potential sponsors for this year’s High Times Cannabis Cup SoCal: People’s Choice Edition 2024 will have all entry fees waived. We also offer multiple tiers of sponsorship, including General, Bronze, Silver, and Presenting Sponsorships. That sums up the details of our event this year but check out our High Times Cannabis Cup website to view all of the details. For a sense of what to expect, check out who shined and who took home awards at the past several years of SoCal Cannabis Cup events. Last year’s winners highlighted known and respected brands including Fig Farms, Team Elite Genetics, Papa’s Select, Top Shelf Cultivation, Maven Genetics. In 2022, we were also amazed with what we saw at the 2022 SoCal: People’s Choice Edition. That year, winners such as Top Shelf Cultivation’s Whoa Si Whoa, Sense’s Pink Certz Flower, Wizard Trees’s Studio 54, and Team Elite Genetics’s Pearadise Flower took home many titles. You can expect to see more surprises this year. Cannabis Cups were first conceived in 1987 by former High Times editor Steven Hager, and slowly spread out from The Netherlands to legal jurisdiction across the world. Join the ranks of the elite and put your product to the ultimate test. May the best brands prevail!

https://hightimes.com/

DEA Celebrates War on Drugs in Cringey Post During Black History Month

On Feb. 1, the official X account of The Drug Enforcement Administration (DEA) posted a photo of former President Richard Nixon and a caption meant to celebrate the legacy of the War on Drugs, but the comment section didn’t go as planned. Making things worse, the DEA posted it on the first day of Black History Month, which is especially ironic given that cannabis laws were unfairly enforced mostly on Black and brown Americans. “On Dec. 14, 1970, at the White House, the International Narcotic Enforcement Officers’ Association presented President Nixon with a ‘certificate of special honor’ in recognition of the outstanding loyalty and contribution to support narcotic law enforcement,” the post reads. The post was marked with a tag for Throwback Thursday, #TBT. A chorus of rebuttals swiftly followed as people asked essentially the same question: Is the drug war something we should be celebrating? People like Cat Packer—the director of drug markets and legal regulation at the Drug Policy Alliance and former executive director of Los Angeles’ Department of Cannabis Regulation—immediately explained why the post is fundamentally wrong on multiple levels. “On the first day of Black History Month 2024 the Biden Administration’s DEA is celebrating President Nixon—this is the same agency responsible for marijuana scheduling,” Packer wrote. Black Americans are arrested for violating cannabis possession laws at nearly four times the rates of white Americans, even though both demographics consume pot at relatively the same rates, the National Organization for the Reform of Marijuana Laws (NORML) notes. This racial disparity in cannabis arrests is much worse in certain areas. For instance in New York, a 2021 analysis of cannabis-related arrests in New York City’s five boroughs during 2020 reported that people of color made up 94 percent of people who were arrested. If laws cannot be enforced equally on the people, after decades of attempts, then why enforce them at all? “It is an incredible affront to do Nixon today. You should remove this post. Nixon did more to harm the black community than any other President in the 20th century. And he did it with the War On Drugs,” Erik Radle, CEO of The Miller Ad Agency wrote in response. Nixon’s own administration now admits that the War on Drugs—particularly the war on cannabis—was intentionally used as a weapon to target Black Americans and anti-Vietnam War demonstrators. John Ehrlichman, who worked under Nixon and was a Watergate co-conspirator, blew the whistle in Harper’s Magazine in 2016—fully admitting the racist intentions of the Nixon administration in launching the War on Drugs. “You want to know what this was really all about?” Ehrlichman asked. “The Nixon campaign in 1968, and the Nixon White House after that, had two enemies: the antiwar left and black people. You understand what I’m saying? We knew we couldn’t make it illegal to be either against the war or black, but by getting the public to associate the hippies with marijuana and blacks with heroin, and then criminalizing both heavily, we could disrupt those communities. We could arrest their leaders, raid their homes, break up their meetings, and vilify them night after night on the evening news. Did we know we were lying about the drugs? Of course we did.” Nixon unceremoniously resigned from office under Section 1 of the 25th Amendment on August 9, 1974 when his impeachment materialized and became imminent. Throughout the history of America, only Andrew Jackson, Bill Clinton, and Donald Trump (two times) were impeached in the House, however only Nixon was completely removed from office. Other presidents may have picked up in Nixon’s footsteps. The Atlantic ran an expose in 2019 on recently uncovered audio, captured in October 1971, alleging that then-California Governor Ronald Reagan held a damning conversation with Nixon before ascending to the Oval Office. The audio transcript shows how Reagan singled out and disparaged Black Americans before his presidency. Famously, Reagan was the president who launched the War on Drugs 2.0 along with First Lady Nancy Reagan, the “Just Say No” era when the federal government ramped up attacks on cannabis consumers and drug users. The recent post on Feb. 1 shows the level of denial in the DEA about the success of the War on Drugs and how out of touch they are with the public. It wasn’t a success: Overdose deaths continue to hit all-time highs, billions of dollars are wasted, and the drug laws aren’t enforced fairly on Black and brown Americans.

https://hightimes.com/

Humboldt Weed Grower To Pay $750,000 for Environmental Violations

A Humboldt County cannabis grower will pay at least $750,000 to settle a dispute with state water and wildlife agencies over alleged environmental violations at a 435-acre cultivation site in California’s famed Emerald Triangle. In the settlement agreement, licensed weed grower Joshua Sweet and his companies, The Hills LLC and Shadow Light Ranch LLC, admitted to violations of state water regulations over a period of several years. “It is critical for all cannabis cultivators to be environmentally responsible and protect California’s water supply and water quality,” Taro Murano, program manager for the State Water Board’s Division of Water Rights cannabis enforcement section, said in a statement from the California Department of Fish and Wildlife (CDFW). “Sweet chose to operate his business while ignoring regulations designed to protect the environment. He must now remediate the environmental damage he caused and pay a significant penalty. No one should get a business advantage by ignoring the law and harming the environment.” The settlement calls for Sweet to pay $1.75 million for the violations, which include illegally diverting and collecting water from unnamed tributaries of the South Fork Eel River that cross the property. According to the settlement terms, $1 million of the fine was suspended, but Sweet will be responsible for paying the additional $1 million if remediations to the property are not completed as agreed. The settlement cites several violations, including building an unpermitted pond on a waterway to collect water for irrigating cannabis plants. Other violations include the destruction of wetland habitats and stream channels, converting oak woodland to cannabis cultivation and failure to work with state and local officials to satisfy permitting requirements. Yvonne West, director of the State Water Resources Control Board’s office of enforcement, said that Sweet and his companies did not have the authority to divert water on the property and use it for cannabis cultivation. According to an email from the water board to nonprofit news outlet CalMatters, Sweet took about 16.2 acre-feet of water, approximately enough to supply about 49 households for a year, for a total of three ponds on the property between 2017 and 2020. “This case represents years of hard work by dedicated staff to remediate damage to streambed channels, wetland habitat and oak woodlands,” said Nathaniel Arnold, acting chief of law enforcement for CDFW. “The settlement also speaks volumes to the egregious nature of this case and should send a strong message to those working outside of state regulations to cultivate cannabis. Our natural resources deserve to be respected.” Included in the settlement agreement is a $500,000 payment for water rights violations, a record penalty for such a violation in the state of California. The defendants are also required to remove unpermitted ponds and restore wetlands and waterways as part of the agreement. Sweet believes that the fines are unfair and excessive and that the case could have been handled differently. “If the full penalty and remediation costs were due today it would take everything I own,” Sweet said in a statement to CalMatters. “Although I will follow through with my end of the settlement, I do not believe this is fair or just, and I believe I have already suffered way too much,” Sweet said in the emailed statement. “Even during our court-mandated settlement conference, they were asked why they would go after a small independent businessman with these type of enormous fines usually reserved for huge corporations that destroy ecosystems,” he added. But state and local officials defended the settlement, saying it is justified by the actions taken at the property. “The ordered penalties are modest given the scope of damage, the length of time the site has been left unremediated and considering the unjust enrichment or benefit to Mr. Sweet from running a business for several years without going through the necessary permitting process,” said Jeremy Valverde, assistant chief counsel at the California Department of Fish and Wildlife, in a statement emailed to CalMatters. Joshua Curtis, the North Coast Regional Water Quality Control Board’s assistant executive officer, said that Sweet and his businesses “for years resisted our attempts to cooperatively work on restoration and recovery of those resources, leaving formal enforcement as our only option.” “This was an ongoing use by Mr. Sweet and the penalties are over an approximately four-year period for unauthorized diversion and use of water to support cultivation,” said West of the water board. “Five hundred dollars a day, multiple violations over a four-year period, does really add up. And then again we did have the additional types of violations at play here as well.”

https://hightimes.com/

Germany’s Coalition Government Reaches Deal on Weed Legalization

The groups that form Germany’s coalition government struck a deal last week on cannabis legalization, setting the stage for the new law to take effect in the spring. Now, the proposal will be considered by the country’s parliament, with a vote expected later this month. Zeit, a German publication, reported last week that the “government coalition made up of the SPD, Greens and FDP has agreed on the details of the legalization of cannabis,” and that the “law could come into force on April 1st, but must first be approved by the Bundestag and Bundesrat.” According to the outlet, Karl Lauterbach, Germany’s federal health minister, “is aiming for approval in parliament in the week from February 19th to 23rd.” In a post on X last week, Lauterbach hailed the agreement by the groups within the coalition. “The fight against the black market, decriminalization and better protection of minors will come as announced. The previous drug policy has failed, a new beginning,” Lauterbach said. The agreement keeps the country on course that the so-called “Traffic Light coalition” laid out late last year. In November, the SPD, Greens and FDP said they had reached a breakthrough in their negotiations of the new cannabis law. “The #Cannabis law is coming! Finally: We are finally ending the failed ban policy! After intensive negotiations, there is now a law that focuses on youth and health protection, ends criminalization and is practical,” the Green Party’s spokesperson Kirsten Kappert-Gonther said in a post on social media at the time. According to Forbes, the “path to legalization in Germany has encountered several hurdles,” including the coalition government having to “revise its plan, which initially involved the sale of cannabis, as it risked breaching EU laws.” Forbes reported that the coalition also “confronted criticism from opposition parties seeking to obstruct the proposed legislation,” as well as “internal dissent within the government, particularly from the SPD, emerged regarding the details of the bill.” The outlet Legal Tribune Online said that the agreement last week signaled that “resistance from the ranks of the SPD parliamentary group against the Cannabis Act (CanG) has apparently been overcome.” Late last year, Legal Tribune Online reported that “health politician Dirk Heidenblut MdB, who is responsible for the issue of cannabis in the SPD parliamentary group, announced over the weekend via social media that the final reading of the Cannabis Act (CanG), which was actually planned for the last week of the year, was taking place. does not come about.” “The reason: The leadership of his SPD parliamentary group expressed concerns about the set-up. The avowed legalization friend explained in a video that he could not understand this, but the implementation would now be postponed until next year. Heidenblut did not want to reveal any further details,” the outlet reported at the time. “The short-term veto of the SPD parliamentary group against the final resolution surprised not only the so-called cannabis community, but also the coalition partners.” Kappert-Gonther said at the time that it was “extremely unfortunate that cannabis is not on the agenda so far,” and that passage of the reform “would have been possible.” But last week’s agreement by the parties indicates that those disagreements have been resolved, and that Germany is now set to enter a new era of cannabis legalization. In a statement, the leaders of the coalition said that the “regulations are a real milestone for a modern drug policy that strengthens prevention and improves health, child and youth protection,” as quoted by Legal Tribune Online. According to Forbes, the agreement “clears the path for the legalization of cannabis for personal use, aligning with the impending vote,” and that, absent any additional delays, “Germany is poised to become the third European Union member state to legalize cannabis for personal use, following Malta and Luxembourg.” “For the government coalition, the legalization of cannabis for personal use marks a significant milestone in modern drug policy, emphasizing prevention and improving health and child and youth protection,” Forbes reported. “However, the proposed legislation, introduced last year by Federal Health Minister Karl Lauterbach, may undergo additional slight revisions to address concerns raised by the SPD, potentially involving the expansion and acceleration of monitoring and reporting obligations related to the illicit market.” Forbes said that lawmakers “recently revised the bill to ease restrictions opposed by advocates and supporters in the Bundestag,” with changes including “raising home possession limits and eliminating the possibility of jail time for slightly exceeding the possession limit.” “The government coalition also plans to introduce a complementary measure establishing pilot programs for commercial sales, set to be revealed after submission to the European Commission,” Forbes said, adding that, if the proposal passes the parliament in the next two months as expected, the ban on pot will be lifted by April 1, and that adults will be able to “grow cannabis at home and possess small quantities, while cannabis clubs will be allowed from July 1.”

https://hightimes.com/

Travis Barker Talks Moving into Adult-Use Space, Touring, and Barker Canna Co.

Today Travis Barker—the lauded drummer of recently reunited Blink-182, Transplants, Goldfinger, and more—announced the launch of Barker Canna Co., after founding CBD brand Barker Wellness last April. The concept is to provide quality cannabis products that are capable of promoting both creativity and wellness, and the rigors of touring pushed Barker into the potent side of the cannabis space. Barker Canna Co. initially launched in California at The Syndicate dispensary locations with plans to expand throughout the state. The company will likely expand in other states with legal cannabis markets in 2024. The Barker Canna Co. will roll out everything from live rosin and full-gram vapes, gummies, and mini-infused pre-rolls. The vape hardware for the live rosin and full-gram vape products was developed by Jupiter Research, known experts in the field. Hemp-derived products are regulated entirely differently from adult-use cannabis products in California. So what in fact prompted Barker’s decision to move from hemp-derived CBD products to state-legal potent cannabis? “The decision to expand from hemp-derived CBD products to state-legal potent cannabis was driven by a strategic response to the evolving cannabis landscape and consumer preferences,” Barker tells High Times. Things have been good lately for the drummer: Last month, Barker kicked off the Emmys—something he’s been waiting “all his life” to do, performing Phil Collins’s “In the Air Tonight” along with an entourage of performers, Anthony Anderson and a choir from Compton, California. Blink-182’s “All the Small Things” just hit one billion streams on Spotify, joining the “Billion Club.” The band’s last album One More Time was released on Oct. 20, 2023, prompting an extended world tour. Cannabis became the answer to a life constantly on the road, he explained, and part of it was about his own recovery process. The momentous, four-leg Blink-182 reunion world tour will take Barker from Madrid to Melbourne by the time it’s over. This means nearly 100 shows, over 40 in North America and dozens more in Europe, Latin American, and Oceania—imagine the toll that level of touring would take on a person’s body. “Initially seeking balance amid a chaotic lifestyle, cannabis, especially edibles, became my recovery go-to,” Barker says. “For me personally, it’s about aligning mentally and physically with my chosen lifestyle. Today, my relationship with cannabis is sophisticated, focusing on balance, creativity, well-being, and positive vibes. Barker Canna Co. is born from this journey, offering quality products to share what I’ve learned.” The brand features items like vegan and gluten-free Mini Peanut Butter Cups or hard-hitting Live Rosin All-In-One Vapes. But one thing that stood out to us are the Barkies—packs of five mini pre-rolls dipped in kief. These come in strains like Rainbow OG Popsicle or Blackberry Diesel. He plans on expanding Barker Canna Co. products to other state-legal cannabis markets in the near future. It’s a state-by-state process different from selling hemp-derived products legal under the 2018 Farm Bill. “California is our starting point, laying down the groundwork for our brand,” Barker says. We plan to expand throughout the state and other legalized states in 2024 so stay tuned. We’re keeping it flexible and ready for whatever comes our way.” Occasionally High Times staff goes to The Syndicate—some locations having a false library wall for a pretty badass retro speakeasy aesthetic. The velvet-lined walls take you back 100 years to the Roaring ‘20s. It’s a vibe if you’ve never been to one. “I’ve been going to The Syndicate for years,” Barker recalls. “They have an incredible team and amazing product selection. As a result, they have become my go-to trustworthy cannabis retailer. Their vibe is really cool and I always have the best experience going into their stores.” Barker and Blink-182 are currently on the Australia leg of their tour, so there’s a lot more work to do, and a lot more recovery. Barker was only about 17 and a known stoner in school when Blink-182 formed, long before fame, marrying a Kardashian, and reality television. And the last time the original line-up of Blink-182 performed was in 2014—a decade ago. So what will he do to prepare for the tour? “My prep work for touring looks a lot different than it used to!” Barker, 48, laughs. “I try to stay as active as possible and make sure I really take care of myself and recover when I have down time. Using the Barker Wellness and Barker Canna Co. products helps with this journey—whether it’s to alleviate muscle pain or spark creativity. Maintaining stamina and strength is crucial for what I do so I’m constantly practicing so I can perform at my best.” Visit a The Syndicate location throughout California to find Barker Canna Co., developed in part by Barker.

https://hightimes.com/

LGBTQ+ Advocates Call Out LCB in Recent Raids at Gay Bars

A group of gay bar owners and LGBTQ+ advocates recently released a joint statement regarding recent “visits,” which they describe as raids, conducted by the Washington State Liquor and Cannabis Control Board (LCB) at their businesses in the Capitol Hill neighborhood. The LCB told bar owners on Jan. 26 and 27 that law enforcement observed violations of the law often called the “lewd conduct law,” which requires employees and patrons to clothe specific parts of their bodies. A coalition of these advocates release a statement on Instagram on Jan. 29 about the raids, including Joey Burgess (The Cuff Complex and Queer/Bar), Keth Christensen (The Seattle Eagle), Kevin Kauer (Massive), Dan Savage (podcast host and author), Terry Miller (founder of the It Gets Better Project alongside his husband, Savage), and Kurt Olivo, and called on advocates to attend an LCB meeting on Jan. 30. “We are issuing this statement to express our concern over recent events targeting gay men. Specifically, unjust raids were conducted by the Joint Enforcement Team (JET) and the Liquor Control Board at several historic gay bars, by extension threatening all active LGBTQ nightlife venues,” the statement said. “Our coalition consists of establishments that provide safe spaces for diverse and marginalized communities to express themselves through love, music, dance, and art. The recent raids have disrupted these operations and undermined trust and security within our community.” The statement continued to explain that none of the venues within the coalition have ever previously been cited for alcohol or violent offenses, and at most, citations related to an individual’s clothing, such as “being shirtless or wearing a jockstrap.” Furthermore, raids on LGBTQ+ businesses have historically persecuted marginalized communities in their safe spaces, and the most recent events cause the relationship between the LGBTQ+ community and law enforcement to be challenged. In response, the coalition statement called for an investigation into the LCB raids. “Our coalition remains committed to fostering positive relations with all stakeholders, emphasizing the need for mutual respect and an understanding of the unique challenges faced by gay, and by extension, LGBTQ+ community as a whole,” the statement concluded. “This statement serves as a call for justice, equality, and the protection of the rights and dignity of our community members.” The coalition, alongside other residents and advocates, attended an LCB meeting on Jan. 30, where members of the community called out the LCB. “These were raids. Stop calling them visits. If everyone in a bar leaves when you show up, 10 of you in uniform with flashlights, they are not experiencing your presence as a social call,” Savage said. “The message sent was if they are raiding gay bars in Seattle, if they are harassing gay men for being shirtless in gay bars in Seattle, we are winning—the bigots are winning.” According to King5, the LCB also had individuals taking photographs in the bars to obtain evidence of “lewd conduct.” The LCB investigators didn’t make their visit or their identity known to business owners or patrons at the time. “Taking pictures without consent of gay men and then posting those pictures as evidence is immoral,” said an unnamed speaker at the meeting. Savage described the LCB raid as a violation, rather than a “visit,” and explained that the photos are subject to the Public Disclosure laws which means they will be released to the public once the investigation has been completed. “Not all the men who go to the Eagle are out of the closet in all areas of their lives. Men could lose their jobs or homes once these photographs are released,” wrote Miller on Instagram on Jan. 31. “LCB officers knew these photos would become a part of the public record. LCB officers knew each photo they took had the potential to ‘cause harm to the depicted person.’” At the meeting, LCB Director David Postman stated that the violations were recorded during the usual enforcement duties conducted by LCB officers. Postman also acknowledged the LCB’s history with the LGBTQ+ community in the past, and he and two other board members agreed to prevent incidents like the raids from happening again. Washington State law, also referred to as the “lewd conduct law,” prohibits such conduct for any business that holds a liquor license, including employees or patrons being unclothed and exposing parts of the body “to view any portion of the breast below the top of the areola or of any portion of the pubic hair, anus, cleft of the buttocks, vulva, or genitals,” among many other examples. King5 wrote that the law was intended to prevent strip clubs from serving alcohol, but Postman commented that changes to the law are being reconsidered in the Washington legislature. “The lewd conduct law, it’s problematic, just talking about my personal point of view here,” Postman said. However, Postman also added that even if the law is archaic, they must continue to enforce it until changes are made. “When there’s laws on the books, it’s really hard to just say ‘Well, we’ve decided not to enforce that one’—the lawmakers, the legislature doesn’t like that, and for good reason,” said Postman. “I can tell you; there is no crackdown on lewd conduct right now, there is no crackdown on gay clubs, there’s no crackdown on clubs in Seattle or anywhere else. We’re doing our normal business here.” LCB board member Jim Vollendroff also spoke at the meeting, ensuring members of the LGBTQ+ community that they will seek a way to prevent it from happening in the future. Likewise, Seattle Mayor Bruce Harrell also issued a statement about the LCB inspections, acknowledging community concerns. “Under my administration, we will not target people or communities based on their sexuality,” Harrell said. “We understand concerns raised by the community based on a perception of violating this principle.” Last year in July, a new cannabis ordinance took effect, which offers labor protections for employees, which “will help provide a stable workplace, stronger workforce, and contribute to a better overall economy for Seattle.”

https://hightimes.com/

Drug Maker Unveils Experimental Drug as Opioid Alternative

A pharmaceutical company unveiled an experimental new drug that is being touted as a less dangerous alternative to opioids. To date, few drugs have demonstrated enough power to manage higher levels of pain often associated with post-surgery recovery. WXYZ Detroit, an ABC affiliate, reports that Vertex Pharmaceuticals said Tuesday the drug’s use in late-stage clinical trials resulted in “clinically meaningful reduction in pain,” without many of the risks associated with opioids. The new drug is called VX-548 and it’s showing promise in early stages. Two trials demonstrated that patients who recently came out of surgery who received Vertex’s new drug had statistically significant pain relief. Phase 2 trial results were published Dec. 13, 2023, noting its effects on painful diabetic peripheral neuropathy. Researchers in a third trial observed a wider range of pain-related conditions. Phase 3 trial results were published on Jan. 30, 2024 and showed “clinically meaningful reduction in pain from baseline in both the abdominoplasty and bunionectomy randomized controlled trials,” as well as many other surgery-related conditions. Participants who used the drug for up to 14 days also noted positive results, with over 83% of patients saying VX-548 was “good” to “excellent” at managing pain. Vertex noted VX-548 was “safe and well-tolerated in all three studies,” but it failed to work better than hydrocodone bitartrate/acetaminophen, aka Vicodin. The National Library of Medicine notes that pain is a complex phenomenon, and that one type of painkiller won’t work for all situations. Vertex plans to submit a New Drug Application to the U.S. Food and Drug Administration (FDA) by mid-2024 regarding VX-548’s treatment of moderate-to-severe acute pain. Vertex’s Phase 1-3 trials move the company closer to gaining approvals from the FDA. If they are successful, it could provide people in the U.S. with another pain treatment option. The vast majority of drug overdoses in the U.S. continues to be dominated by opioids. And to make things worse, the confusion over addiction leads to making it harder for patients who actually need opioids to get them prescribed. According to The National Center for Health Statistics (NCHS) under the U.S. Centers for Disease Control and Prevention, drug overdose deaths rose from 2019 to 2021 with over 106,000 drug overdose deaths reported in 2021. Deaths involving synthetic opioids—primarily fentanyl and excluding methadone—continued its death march with 70,601 overdose deaths reported in 2021. Fentanyl in particular kills 150 Americans per day. Many other attempts to develop alternatives to opioids that effectively dull pain, but they typically fail. If Vertex’s drug is ultimately deemed to be safe, it could introduce a new class of acute pain medicine for the first time in about 20 years, Dr. Jessica Oswald told WXYZ. “As a physician treating patients suffering from pain for many years, I know firsthand the critical need for new, efficacious and safe treatment options,” Oswald said. “The Phase 3 safety and efficacy across the three studies are impressive and demonstrate VX-548’s potential to change the paradigm of pain management.” Opioids kill more Americans than car crashes or gun violence. An alternative to effective, but highly dangerous opioids, some of which having the power to stop breathing, is sorely needed. Bayer introduced heroin in 1898 and called it a “wonder drug” meant to be less addictive than morphine, which was ravaging America at the time with drug addicts. It wasn’t until over 10 years later that an army of heroin addicts emerged. Cannabis itself has been explored as an opioid alternative, but it works in very different ways. One study is taking a closer look at the specific holistic effects that both medical cannabis and opioids provide to get more insight on the efficacy of each substance as it pertains to chronic pain management. The recent study, “The holistic effects of medical cannabis compared to opioids on pain experience in Finnish patients with chronic pain,” was conducted by a team of researchers from Åbo Akademi University, who looked into the effects of medical cannabis and opioids for chronic pain treatment. Published in the Journal of Cannabis Research, the study aimed to take a closer look at how effective medical cannabis is compared to traditional opioids in treating chronic pain, as cannabis use for symptom management has become increasingly more common in recent years. Results suggested that opioids and cannabis are both “equally efficacious” at mitigating pain intensity in patients with chronic pain, while cannabis offered more “holistic” relief in improving sleep, focus and emotional wellbeing. Vertex Pharmaceuticals could help provide a safer alternative compared to typical opioids that have created an epidemic of drug overdoses in the U.S.

https://hightimes.com/

Massachusetts Cannabis Business Owners’ Lawsuit Against the U.S. Government Continues

The saga continues for four Massachusetts-based business owners who filed a lawsuit against the U.S. Justice Department in an attempt to overturn cannabis prohibition. The plaintiffs include owners of Canna Provisions, Inc., Gyasi Sellers, Wiseacre Farm, Inc., and Verano Holdings Corp., who are represented by David Boies and Josh Schiller of Bois Schiller Flexner LLP. The lawsuit was first issued in October 2023, and used the results of a court case from 2005, Gonzales v. Raich, to showcase how federal prohibition of cannabis is outdated. “The federal criminal prohibition on intrastate marijuana remains in place, an unjustified vestige of a long-abandoned policy,” the lawsuit states. “This unjustified intrusion of federal power harms Plaintiffs, threatens the communities they serve, and lacks any rational purpose.” According to a news report published by The Boston Globe, U.S. Attorney General Merrick Garland filed a motion to dismiss the case on Jan. 23, stating that the plaintiffs have no standing on which to sue, and have presented no evidence that prohibition has caused them injury (such as being arrested or prosecuted). The motion stated that “Even if the court were free to disregard Raich ’s holdings (it is not), Plaintiff’s attacks on that holding are unpersuasive,” that the “Plaintiffs lack standing to challenge the CSA [Controlled Substances Act],” and “Courts have consistently, and correctly, held that no fundamental right exists to distribute, possess, or use marijuana.” The Boston Globe noted that the Department of Justice declined to comment, as of Jan. 29. In defense of the business owners, Schiller described how there is evidence that the longstanding illegality of cannabis from a federal standpoint is “well-established.” Schiller cited examples such as cannabis businesses being heavily taxed, forced to pay insurance premiums, cannot take credit cards as a form of payment, and usually pay a higher price for rent or mortgages, “Almost like they are illegal businesses.” James Smith, of Smith, Costello, & Crawford, commented on the lawsuit and told The Boston Globe that winning a case like this one is a “high hill to climb.” Even still, Smith described Massachusetts’ regulatory framework for legalization as “pretty pristine.” The federal government has yet to make a move on federal legalization and has made no constructive decisions regarding major industry issues, such as banking. Smith added that with a lack of action from the federal government, that leaves state legislators to act—and courts are waiting for them to do so. Another comment was provided by Boston University professor and author, Jay Wexler, who told the news outlet that if legislators lose interest in regulating cannabis federally, then expecting the federal government to take on the role of cannabis business in all states “falls apart.” Wexler also stated that this current case could eventually reach the Supreme Court. “These are cases where plaintiffs are aiming for the Supreme Court because there are precedents,” said Wexler. “It’s pretty unlikely that lower courts will feel comfortable agreeing with the plaintiffs.” Schiller estimated that the lawsuit could take two years to reach a conclusion. But one of the plaintiffs, Gyasi Sellers, who owns a delivery service called Treevit, explained that it’s worth the wait. The opportunity to freely and legally take credit cards as a form of payment would improve his entire business, making delivery quicker and also maintaining a safe work environment for employees. Sellers described how prohibition would be “like getting our training wheels taken off, or our handcuffs taken off, depending on how you want to look at it. It’d be nice to say our fate is actually in our hands, and we have the ability to reach our true potential.” The support for putting an end to prohibition continues to grow. Following the recommendation to move cannabis from a Schedule I to a Schedule III substance by the U.S. Department of Health and Human Services, the industry eagerly awaits the decision of the Drug Enforcement Administration. Meanwhile, multiple House representatives and Senators are calling out to President Biden to make a move as well. In a High Times exclusive interview, New York Senator Kristen Gillibrand called for an end to prohibition. “Studies show that legalizing marijuana could help reduce violence in international drug trafficking and generate billions of dollars for the economy,” Gillibrand said. “The vast majority of Americans agree that marijuana should be legalized—that’s why I’m calling on the Attorney General and the Drug Enforcement Administration to swiftly deschedule marijuana from the Controlled Substances Act.” Many predict that rescheduling cannabis could give Biden a huge boost in the upcoming election later this year. A survey conducted by Lake Research Partner showed that Biden could benefit from an 11% boost from younger voters (based on the opinions of 900 voters used in the survey, spread out across the U.S.).

FAQ: How to use this hemp news hub

What topics does Chow420’s hemp news cover?

We aggregate and surface reputable coverage on hemp laws and enforcement, THC thresholds and policy proposals, cannabinoid products (CBD/Delta-8/hemp-derived THC), compliance, lab testing, recalls, and broader industry news.

Is this legal advice?

No. This page is for news and education. Hemp rules can change quickly and vary by state—always verify against the latest official guidance and consult qualified counsel for compliance decisions.

How do I evaluate hemp product safety claims?

Look for current third‑party COAs (Certificates of Analysis), clear ingredient labeling, and transparent sourcing. Be cautious with vague potency claims or missing lab reports.

Why do some articles mention Delta‑8 or “hemp-derived THC”?

These products often sit at the center of policy and enforcement changes. We track major updates so shoppers and brands can understand evolving requirements and market impacts.

How often is the news updated?

The crawler is scheduled to run daily. New items appear as sources publish updates.

CBD Forum by Chow420

Hemp News, Laws & Product Updates

Gallup: 17% of American Adults Smoke Pot

‘Old Smoker’ Star Discovered Lurking in Milky Way Galaxy

Sen. Elizabeth Warren Advocates for Cannabis Descheduling on ‘The Late Show’

Binoid’s Best THC Vapes of 2024

Pennsylvania Governor Calls On State Lawmakers To Legalize Weed

Mary Jones Cannabis Bringing Its Soda, Edibles to Canada

Magic Mushrooms Busts Up Amid Renewed Interest in Psychedelics

Grateful Dead Break Billboard Record Almost 30 Years After Disbanding

New Jersey Introduces Digital MMJ Cards With No Registration, Renewal Fees

Cannabis Business Presence Increasing on the Colorado Tourism Office Website

Announcing the High Times Cannabis Cup SoCal: People’s Choice Edition 2024

DEA Celebrates War on Drugs in Cringey Post During Black History Month

Humboldt Weed Grower To Pay $750,000 for Environmental Violations

Germany’s Coalition Government Reaches Deal on Weed Legalization

Travis Barker Talks Moving into Adult-Use Space, Touring, and Barker Canna Co.

LGBTQ+ Advocates Call Out LCB in Recent Raids at Gay Bars

Drug Maker Unveils Experimental Drug as Opioid Alternative

Massachusetts Cannabis Business Owners’ Lawsuit Against the U.S. Government Continues

FAQ: How to use this hemp news hub

Forgot your password?